{"gao_id": "GAO-23-105245", "published": "2022-12-19T12:00:00Z", "released": "2022-12-19T07:00:00Z", "summary": "Despite more than 3 decades of government policies to improve diversity in clinical cancer trials, certain groups remain underrepresented, including some racial and ethnic groups, women, and low-income individuals. Diversity in clinical trials aims to ensure safe and effective treatments for any patient likely to use them. To increase diversity in federally-funded clinical cancer trials, agencies broadened eligibility requirements, reimbursed patient out-of-pocket costs to reduce...", "title": "Cancer Clinical Trials: Federal Actions and Selected Non-Federal Practices to Facilitate Diversity of Patients", "topics": ["Cancer centers", "Health care", "Medical research", "Clinical trials", "Communities", "Racial and ethnic groups", "Cancer screening", "Health Care", "Patient care", "Cancer", "Cancer research"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-105245", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-23-105245-highlights.pdf"}, {"title": "Full Report (79 pages)", "url": "https://www.gao.gov/assets/gao-23-105245.pdf"}, {"title": "Accessible PDF (82 pages)", "url": "https://www.gao.gov/assets/820/814351.pdf"}]}